Concert Pharmaceuticals, Inc.
Morphinan Compounds
Last updated:
Abstract:
This disclosure relates to novel morphinan compounds and their derivatives, pharmaceutically acceptable salts, solvates, and hydrates thereof. This disclosure also provides compositions comprising a compound of this disclosure and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a al receptor agonist that also has NMDA antagonist activity.
Status:
Application
Type:
Utility
Filling date:
14 Dec 2020
Issue date:
11 Nov 2021